Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Follicular Lymphoma: A Phase I Trial.
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Azacitidine (Primary) ; Cyclophosphamide; Rituximab; Vincristine
- Indications Follicular lymphoma
- Focus Adverse reactions
- 13 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2016 Status changed from active, no longer recruiting to completed.
- 14 Nov 2013 Planned end date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.